Vectura Group PLC (VEC.L)
23 Jan 2017
Wed, Nov 23 2016
* H1 pretax loss -18.6 million stg versus -2.7 million stg loss year ago Source text for Eikon: Further company coverage: (Reporting By London Bureau)
* Announces agreement with Vectura for development of generic salmeterol for U.S. market Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)
LONDON James Ward-Lilley, the former AstraZeneca executive who created a UK respiratory medicine business in June by merging Vectura and SkyePharma, is already thinking about his next deal.
Sept 7 Drugmaker Vectura Group Plc said it raised its revenue expectations for the nine months to Dec. 31 following strong trading to the end of August.
Aug 30 Respiratory drug specialist Vectura Group Plc said its asthma therapy Flutiform had not met the primary endpoint in a phase III trial carried out by its European partner Mundipharma.
* Vectura initiates legal proceedings against GlaxoSmithKline Plc (GSK)
- Vectrus' (VEC) CEO Kenneth Hunzeker on Q3 2016 Results - Earnings Call Transcript
- Vectrus 2016 Q3 - Results - Earnings Call Slides
- You Must Be Crazy! (YMBC) -A Small Cap Value, High Yield Portfolio - Q3 2016 Review
- Vectrus - Selloff Sleeper Presents Attractive Opportunity
- Vectrus' (VEC) CEO Ken Hunzeker on Q2 2016 Results - Earnings Call Transcript
- Vectrus 2016 Q2 - Results - Earnings Call Slides